Part 2 - Improving cancer outcomes and leadership course: a European initiative
Part 2 - Improving cancer outcomes and leadership course: a European initiative
11/02/2027 18:00
Arrivals & Registration
12/02/2027 08:30
Welcome and Introduction
12/02/2027 09:00
Session 1: Overview of strategic approaches to improve Europe’s cancer outcomes and what it means
09:00
New actions & initiatives
Mark Lawler (UK)09:10
Patient Advocates’ Perspective
09:20
Update of the European Cancer Code of Cancer Practice
Peter Selby (UK)09:30
Discussion
Razvan Popescu (CH)12/02/2027 09:45
Session 2: Previous cohort - Update on initiatives and challenges to improve clinical practice
09:45
RISING-RO: From Mapping Inequities to Building a Regional Radiotherapy Leadership Platform in South-East Europe
Milos Grujic (RS)09:55
Is prioritization on rare cancers luxury or necessity in developing countries?
Bruna David (BR)10:05
Discussion
12/02/2027 10:30
Coffee break
12/02/2027 11:00
Session 3: Strategic Approaches to Oncopolicy
11:00
Strategies in other Countries - use of resources, share of clinical burden
Richard Sullivan (UK)11:20
Place based Cancer Care - Case Study
David Nelson (UK)11:30
Discussion
Peter Selby (UK)12/02/2027 11:45
Session 4: Effective and Efficient Cancer Care
11:45
Factors Determining Effective and Efficient Cancer Care
Ajay Aggarwal (UK)12:05
Implementation and hurdles of applying factors in the clinic
Assia Konsoulova (BG)12:15
Discussion
Razvan Popescu (CH)12/02/2027 12:30
Lunch
12/02/2027 13:30
Session 5: Patient Advocates role in shaping care and improving outcomes
13:30
What is valuable to patients and how should it be measured
Tanja Spanic (SI)13:45
Advocacy influencing government level & survivorship
14:00
The role of patients in trial development
14:15
Discussion
12/02/2027 14:30
Parallel Workshops: Leadership
14:30
Leadership - Group 1
14:30
Influencing & Negotiating - Group 2
12/02/2027 16:00
Coffee break
12/02/2027 16:30
Parallel Workshops: Leadership
16:30
Leadership - Group 2
16:30
Influencing & Negotiating - Group 1
12/02/2027 19:30
Group dinner
13/02/2027 08:30
Session 6: Value-based Clinical Decision Making
08:30
Clinical View
Maria-João Cardoso (PT)08:45
Health systems view
Richard Sullivan (UK)09:00
Discussion
Mark Lawler (UK)13/02/2027 09:15
Session 7: Improving Efficiency in Cancer Care
09:15
Improving Efficiency in Cancer Care
09:35
Example
Razvan Popescu (CH)09:45
Discussion
Wendy McInally (UK)13/02/2027 10:00
Coffee break
13/02/2027 10:30
BREAKOUT SESSION 1: Partcipant presentations of initiatives and challenges to improve outcomes
13/02/2027 12:30
Lunch
13/02/2027 13:30
Overview on the impact of AI on how we approach planning cancer services
13:55
Discussion
13/02/2027 14:15
BREAKOUT SESSION 2: Partcipant presentations of initiatives and challenges to improve outcomes
13/02/2027 16:15
Coffee break
13/02/2027 16:45
BREAKOUT SESSION 3: Partcipant presentations of initiatives and challenges to improve outcomes
13/02/2027 20:00
Faculty Dinner (participants free evening)
14/02/2027 08:00
Parallel Advice Clinics
08:00
How to use Patient Advocacy
Tanja Spanic (SI)08:00
Implementation and applications of AI
Maria-João Cardoso (PT) Andre Pfob (DE) Razvan Popescu (CH)08:00
Establishing quality multi-professional interactions
Assia Konsoulova (BG) Wendy McInally (UK)14/02/2027 09:00
Parallel Advice Clinics
09:00
How to use Patient Advocacy
Tanja Spanic (SI)09:00
Implementation and applications of AI
Maria-João Cardoso (PT) Andre Pfob (DE) Razvan Popescu (CH)09:00
Establishing quality multi-professional interactions
Assia Konsoulova (BG) Wendy McInally (UK)14/02/2027 10:00
Coffee break
14/02/2027 10:30
Award for Improving Cancer Outcomes
What we have achieved in the last decade and where we are going
14/02/2027 11:15
Next Steps
14/02/2027 12:15
Closing and departures
Ajay Aggarwal
London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Andre Pfob
Heidelberg University Hospital, Breast Center, Heidelberg, DE
Assia Konsoulova
National Cancer Hospital, Medical Oncology Dept., Sofia, BG
Bruna David
Instituto Nacional do Cancer, Clinical Research Dept., Rio de Janeiro, BR
David Nelson
University Of Lincoln, Lincoln Institute For Rural And Coastal Health, Lincoln, UK
Maria-João Cardoso
Champalimaud Foundation, Breast Unit, Lisbon, PT
Mark Lawler
Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
Milos Grujic
University Clinical Center Kragujevac, Radiation Oncology Dept., Kragujevac, RS
Peter Selby
Lincoln, UK
Razvan Popescu
Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Richard Sullivan
King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK
Tanja Spanic
Europa Donna Slovenia, Patient Advocacy Dpt., Ljubljana, SI
Wendy McInally
EONS President, Edinburgh, UK
